FDA Import Refusal 799-5040264-3/21/2 — AstraZeneca Canada Inc.
The FDA refused shipment 799-5040264-3/21/2 from AstraZeneca Canada Inc. (Canada) on Sep 22, 2021. The refused product falls under Drugs and Biologics — ROSUVASTATIN CALCIUM. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 22, 2021
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61JDB16 ROSUVASTATIN CALCIUM
- Charges
- 75